LAMP1 and renal carcinoma: Our study highlights the potential of LAMP1 as a novel biomarker for diagnosing ccRCC patients and predicting their prognosis, while also providing valuable insights into the underlying molecular mechanisms that could guide targeted therapeutic strategies for renal cancer.